For instance, the phenotype CD127− CD8br AC may represent a specialized subgroup of CD8+ Treg cells that exert potent cytotoxic effects against tumor cells,[45] a discrepancy possibly resulting from different patient cohorts or experimental protocols. This evidence concerns the gene CD8A and neoplasm.